Tardy v. Eli Lilly and Co.

CourtSuperior Court of Maine
DecidedAugust 3, 2004
DocketCUMcv-03-538
StatusUnpublished

This text of Tardy v. Eli Lilly and Co. (Tardy v. Eli Lilly and Co.) is published on Counsel Stack Legal Research, covering Superior Court of Maine primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Tardy v. Eli Lilly and Co., (Me. Super. Ct. 2004).

Opinion

STATE OF MAINE SUPERIOR COURT CUMBERLAND, ss. CIVIL ACTION _ ._ '- r- f?C?CKET NO. CV-03-:p3~/ I ...-; ..... \ oJ ' ­ I ? I ­

DANNY TARDY and DIANE TARDY, Individually and as Personal Representatives of the ESTATE OF MICHAEL TARDY, Plaintiffs ORDER ON ALL v. PENDING MOTIONS

ELI LILLY AND COMPANY, Defendant

Before the Court is Defendant Eli Lilly and Company's Motion to Preclude

the Expert Testimony of Dr. Michael J. Ferenc and Dr. Paul Fitzgerald and

Motion for Summary Judgment.

BACKGROUND Defendant Eli Lilly and Company ("Eli Lilly") manufactures and

distributes a drug known as Zyprexa, which is used to treat Attention

Deficit/Hyperactivity Disorder ("ADHD"). Plaintiffs Danny Tardy and Diane

Tardy ("Plaintiffs"), both individually and as the personal representatives of the

Estate of Michael Tardy ("Michael"), sued Eli Lilly after Michael's death at the

age of 27 in June 2002. The Plaintiffs' Complaint asserts counts of strict liability,

negligence, breach of warranty and fraud against Eli Lilly due to Eli Lilly's

alleged failure to disclose certain side effects of Zyprexa. The Plaintiffs claim

that Michael's long-term use of Zyprexa caused a series of conditions that

ultimately left Michael in a hyperosmotic, hyperglycemic, non-ketotic coma,

which resulted in his death. Eli Lilly now moves for summary judgment on the basis that the Plaintiffs

cannot present sufficiently reliable evidence to show that Michael's injuries were

caused by Zyprexa. Eli Lilly states that "the only potential sources of such

evidence is [sic] Dr. Michael J. Ferenc and Dr. Paul Fitzgerald," Defendant's

Motion for Summary Judgment, page 1, and their testimony is not admissible

because it fails to conform to the Maine Rules of Evidence.

Eli Lilly states that Dr. Ferenc, a forensic pathologist, bases his opinion

that Michael died as a result of taking Zyprexa solely on a postmortem urine

dipstick test, which Eli Lilly states "both scientific literature and various courts

have deemed unreliable." Eli Lilly states that the more "generally accepted"

vitreous test should have been performed immediately postmortem and used by

the Doctors in rendering their opinions. I Eli Lilly objects to Dr. Fitzgerald, an

endocrinologist, on the basis that his opinions are derived solely from Dr.

Ferenc's conclusions, which Eli Lilly believes are unreliable.

Eli Lilly further states that the facts do not support a conclusion that

Michael suffered from a hyperglycemic condition prior to his death. Eli Lilly

points to the medical notes of Dr. John Bell, Michael's psychiatrist, who recorded

that Michael was "fit and healthy" and "playing a lot of basketball" nine days

prior to Michael's death. Eli Lilly also points to the statement of Michael's

mother that Michael appeared fine at a family dinner just days prior to this

death. Finally, Eli Lilly states that Dr. Ferenc failed to take into account an empty

vial of 60 Zyprexa pills found in Michael's bedroom. Eli Lilly argues that these

facts do not support a finding that Michael was in a hyperglycemic crisis.

1 A vitreous test was performed about a year after Michael's death and showed a low level of glucose. The parties disagree as to the reliability of this test as the Plaintiffs argue that the sample was not properly preserved, thus rendering the test unreliable.

2 In sum, Eli Lilly states that Dr. Ferenc's methodology and causation

opinions are unreliable. Dr. Fitzgerald's opinions rely upon Dr. Ferenc's findings

and therefore are likewise unreliable. As such, Eli Lilly argues, the Court should

grant its Motion to Preclude the Expert Testimony of Drs. Ferenc and Fitzgerald.

If the Court grants this Motion to Preclude, Eli Lilly argues, it must also grant the

Motion for Summary Judgment because the Plaintiffs cannot prove causation, a

necessary element of their claims.

STANDARD OF REVIEW

Summary judgment is proper where there exist no genuine Issues of

material fact such that the moving party is entitled to judgment as a matter of

law. M.R. Civ. P. 56(c); Arrow Fastener Co., Inc. v. Wrabacon, Inc., 2007 ME 34, err

15, 917 A.2d 123, 126. "A court may properly enter judgment in a case when the

parties are not in dispute over the [material] facts, but differ only as to the legal

conclusion to be drawn from these facts." Tondreau v. Sherwin-Williams Co., 638

A.2d 728, 730 (Me. 1994). A genuine issue of material fact exists "when the

evidence requires a fact-finder to choose between competing versions of the

truth." Farrington's Owners' Ass'n v. Conway Lake Resorts, Inc., 2005 ME 93 err 9,

878 A.2d 504, 507. An issue of fact is material if it "could potentially affect the

outcome of the suit." Id. An issue is genuine if "there is sufficient evidence to

require a fact-finder to choose between competing versions of the truth at trial."

Lever v. Acadia Hasp. Corp., 2004 ME 35, err 2, 845 A.2d 1178, 1179. If ambiguities

exist, they must be resolved in favor of the non-moving party. Beaulieu v. The

Aube Corp., 2002 ME 79, err 2, 796 A.2d 683, 685.

In response to a defendant's motion for a summary judgment, a plaintiff

having the burden of proof at trial must produce evidence that, if produced at

3 trial, would be sufficient to resist a motion for judgment as a matter of law.

Northeast Coating Technologies, Inc. v. Vacuum Metallurgical Co., Ltd., 684 A.2d

1322, 1324 (Me. 1996). This requires the plaintiff to establish a prima facie case for

each element of the cause of action. Id.

DISCUSSION

In Eli Lilly's words, its Motion for Summary Judgment is "based entirely

on the contention that plaintiffs are without admissible evidence that could

support the conclusion that Zyprexa caused [Michael's] death" because Eli Lilly

asserts that the expert testimony of Drs. Ferenc and Fitzgerald should be

precluded. Maine Rule of Evidence 702 states, "If scientific, technical, or other

specialized knowledge will assist the trier of fact to understand the evidence or

to determine a fact in issue, a witness qualified as an expert by knowledge, skill,

experience, training, or education, may testify thereto in the form of an opinion

or otherwise."

In a line of cases beginning with State v. Williams, 388 A.2d 500 (Me. 1978),

the Law Court has held that in order to be admissible, expert testimony must be

relevant pursuant to M.R. Evid. 401 and will assist the trier of fact in

understanding the evidence or determining a fact in issue. Searles v. Fleetwood

Homes of Pennsylvania, Inc., 2005 ME 94, en 21, 878 A.2d 509, 515-16. In order to

meet this two-part standard for admissibility, expert testimony must also "meet a

threshold level of reliability." In re Sarah c., 2004 ME 152, en 11, 864 A.2d 162, 165.

This threshold does not require general acceptance. Searles, 2005 ME 94, en 22, 878

A.2d at 516 ("General acceptance is not a prerequisite for admission, however").

Rather, "requisite to the admissibility of proffered expert testimony is a showing

of sufficient reliability to satisfy the evidentiary requirements of relevance and

4 helpfulness, and of avoidance of prejudice to the defendant or confusion of the

fact-finder." State v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Sarah C.
2004 ME 152 (Supreme Judicial Court of Maine, 2004)
Lever v. Acadia Hospital Corp.
2004 ME 35 (Supreme Judicial Court of Maine, 2004)
State v. Williams
388 A.2d 500 (Supreme Judicial Court of Maine, 1978)
Tondreau v. Sherwin-Williams Co.
638 A.2d 728 (Supreme Judicial Court of Maine, 1994)
Beaulieu v. the Aube Corp.
2002 ME 79 (Supreme Judicial Court of Maine, 2002)
State v. Boutilier
426 A.2d 876 (Supreme Judicial Court of Maine, 1981)
Northeast Coating Technologies, Inc. v. Vacuum Metallurgical Co.
684 A.2d 1322 (Supreme Judicial Court of Maine, 1996)
Arrow Fastener Co., Inc. v. Wrabacon, Inc.
2007 ME 34 (Supreme Judicial Court of Maine, 2007)
Farrington's Owners' Ass'n v. Conway Lake Resorts, Inc.
2005 ME 93 (Supreme Judicial Court of Maine, 2005)
Searles v. Fleetwood Homes of Pennsylvania, Inc.
2005 ME 94 (Supreme Judicial Court of Maine, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
Tardy v. Eli Lilly and Co., Counsel Stack Legal Research, https://law.counselstack.com/opinion/tardy-v-eli-lilly-and-co-mesuperct-2004.